Massimo Serra

16PUBLICATIONS
78CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Dec 31, 2025
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol.

Juliana Salazar, María J Arranz, Javier Martin-Broto

|Nov 13, 2025
Establishment and Characterization of OS-MET-R-092: A Novel Patient-Derived Cell Culture from an Osteosarcoma Bone Metastasis.

Veronica Giusti, Leonardo Fantoni, Monica Torsello

|Jul 25, 2025
Tumor Immune Microenvironment-Associated Prognostic and Mifamurtide-Response Gene Signatures for Localized Osteosarcoma: A Correlative Study of the ISG/OS-2 Trial.

Emanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri

|May 13, 2025
Correction: Belisario et al. ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. Cells 2020, 9, 647.

Dimas Carolina Belisario, Muhlis Akman, Martina Godel

|Nov 27, 2024
The Interplay Between the MYC Oncogene and Ribosomal Proteins in Osteosarcoma Onset and Progression: Potential Mechanisms and Indication of Candidate Therapeutic Targets.

Ania Naila Guerrieri, Claudia Maria Hattinger, Federica Marchesini

|Apr 28, 2023
Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need.

Silvia Vanni, Valentina Fausti, Eugenio Fonzi

Pageof 3

Frequent Collaborators

7 joint publications

Claudia Maria Hattinger

6 joint publications

Chiara Riganti

6 joint publications

Toni Ibrahim

5 joint publications

Katia Scotlandi